reason smile lift pt org sale
ep estimate littl chang optimist org sale outlook
vs prior off-set higher level invest encourag
cl progress em momentum hill focu premium overal
improv sale trend top-line payback encourag though invest level
particularli us clearli need move higher cl multipl look fair
cl report solid result incl org sale ep in-lin cl report strong
org sale growth vs street better gm off-set higher sg incl
advertis yoy put take gm beat sg miss along
lower interest expens vs model deliv ep in-lin street
top-line momentum encourag co outlook suggest
improv underli trend howev follow period over-earn
come cost invest level set move higher follow cl rebas
cl initi guid call strong org sale growth driven reinvest cl
initi guid call sale grow incl strong org sale growth vs
street benefit filorga hello better gm like
reinvest drive top-line trend result adj ep growth low mid-single-digit
impli vs street come print notabl co
focus turn around share trend na though management expect share growth
like sever quarter away
takeaway confer call em em grow fast
dm cl categori cl deliv em/dm growth latam
perform particularli well w/strength brazil mexico despit macro uncertainti
latter ii coronaviru management expect neg impact least first qtr
though earli assess lt implic iii e-com grew quarter iv
 hello perfect fit given posit toward milleni gen-z
skin management believ right asset filorga eltamd pca ad
think right need never say never lt ep
algo yoy declin low-to-mid-single-digit growth target
partial owe stepped-up invest cl non-committ abil return
high-single-digit
updat model maintain hold ep estimate littl chang
initi guidanc cl appropri focus reinvest aim maintain
strong top-line momentum sequenti improv org sale strength em
encourag co premium strategi appropri howev valuat
look reason ntm price-to-earnings premium hpc peer in-lin yr average
updat pt impli share trade price-to-earnings reiter hold rate w/
better opportun group top pick beverag
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
organ sale growth
oper margin expand bp
bp expans
price target ev/ebitda
ntm ebitda ev/ulfcf
ulfcf
bp top-line volum upsid rebound
bp oper margin upsid increment
product potenti commod tailwind
price target ev/ebitda
ntm ebitda ev/ulfcf
bp top-line volum downsid emerg market
bp margin pressur increas trade
promot unfavor move commod
price target ev/ebitda
ntm ebitda ev/ulfcf
colgat view potenti target larg
colgat oral care franchis among best
busi cpg market share growth
cl lever among coverag recoveri
emerg market
pleas see import disclosur inform page report
street gm better vs
off-set higher sg drive in-lin
ep
net sale growth
 filorga hello
gross margin improv
interest expens slightli
ep low mid-single-digit increas impli vs street
cl initi guid call org
sale vs street ep growth low-
pleas see import disclosur inform page report
actualjef estimate million except incom expens incom compositionreport org sale bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp equiti research
colgat thesi chart
chart despit recent improv near-term macro
competit pressur em like keep cl org sale
growth well histor averag
chart compani face materi moder vs best-
in-class growth
chart expect cl oi growth remain pressur
near-to-intermedi term well growth
chart colgat histor margin enhanc
impress howev recent gm pressur higher
invest weigh margin
chart despit higher margin/fcf profil vs stapl cl
uncertain outlook respect ep flow-through weigh
stock multipl view
chart cl valuat emb littl strateg halo news
report potenti suitor last report quiet
front
pleas see import disclosur inform page report
develop market growth market growth organ sale growth em/dm em/dm org sale growth em org sale growthdm org sale growthtot sale growth fx neutral oi growth org sale growthfx neutral oi margin ebitda margin ebitda right axi gm left org salesgrowthebitda conversionul p/ecl vs peer metric clstapl peer ntm ev/ebitda vs peer nielsen result period end
chart cl four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
pleas see import disclosur inform page report
quarterli sale growth sale growth yoy sale growthtwo-year averag sale growthxaoc ccolgat palmol mixlatest soap-light cleaners-multi sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag us market share dashboard
chart colgat sale growth vs industri growth left portfolio gain market share right
pleas see import disclosur inform page report
us track channel growth vs industri weight industri growthcl sale portfolio gain valu share trail averagetrail ltm averag colgat valuat look fair rel consum
pleas see import disclosur inform page report
pleas see import disclosur inform page report
colgat trade near recent averag vs hpc
chart cl histor ntm price-to-earnings multipl vs
pleas see import disclosur inform page report
summar price target forecast upsid downsid scenario cl
stock base ntm estim util ev/ebitda ev/ulfcf
valuat framework flex upsid downsid scenario rel forecast
ebitda ulfcf net see modest upsid stock
next twelv month tsr upsid scenario call tsr downsid
chart upsid target downsid scenario
pleas see import disclosur inform page report
base ntm estimatesjefblendedtsrimpliedscenariosebitdamultiplepriceulfcfmultiplepricestock scenariosgrowth rebound margin upsid share trade premiumresult remain mute invest year valuat premium returnsgrowth slow margin downsid reinvest valuat discountdownside- volum downsid continu em deceler market share loss- bp margin pressur increas trade promot commodities- valuat blend ev/ebitda ev/ulfcf impli price-to-earnings ev/ebitda volum upsid increment margin rebound em growth- bp margin improv increment product commod tailwinds- valuat blend ev/ebitda ev/ulfcf impli price-to-earnings organ sale growth om expand bp bp valuat blend ev/ebitda ev/ulfcf impli price-to-earnings ev/ulfcf valu driver equiti research
organ sale growth segment
pleas see import disclosur inform page report
colgat organ sale growth total cltwo-year market organ sale growth emerg marketstwo-year market organ sale growth develop marketstwo-year organ sale growth oral two-year america organ sale growth north americatwo-year america organ sale growth latin americatwo-year averag chart europ organ sale growth
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
colgate-palmol diversifi consum product compani develop manufactur market oral care person care
home care pet nutrit product countri territori world-wide compani sell toothpast toothbrush
mouthwash deodor bar soap liquid hand soap bodi wash shave product colgat tom main
prescript diet brand name colgate-palmol headquart new york ny
pt base blend forward ntm ev/ebitda ev/ulfcf methodolog risk em price fx
pt base weight fundamental/strateg ev/ulfcf ev/ebitda forward ntm est risk macro competit
price target base ev/ebitda ev/ulfcf valuat methodolog ntm estim one year plu present
valu canopi warrant risk forecast includ price ration high-end beer cannabi adopt input cost
deceler mexican import segment
pt base weight forward ntm ev/ebitda ev/ulfcf methodolog plu npv compani finite-liv tax
kevin grundi certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
ryan metz certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
pleas see import disclosur inform page report
